1.85
price down icon0.54%   -0.00
after-market Handel nachbörslich: 1.84 -0.01 -0.54%
loading
Schlusskurs vom Vortag:
$1.85
Offen:
$1.83
24-Stunden-Volumen:
2.64M
Relative Volume:
0.37
Marktkapitalisierung:
$16.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.07M
KGV:
-0.1322
EPS:
-13.99
Netto-Cashflow:
$-12.56M
1W Leistung:
+9.52%
1M Leistung:
+207.69%
6M Leistung:
+164.06%
1J Leistung:
-46.04%
1-Tages-Spanne:
Value
$1.75
$1.9199
1-Wochen-Bereich:
Value
$1.70
$2.28
52-Wochen-Spanne:
Value
$0.53
$4.318

Palisade Bio Inc Stock (PALI) Company Profile

Name
Firmenname
Palisade Bio Inc
Name
Telefon
(858) 704-4900
Name
Adresse
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PALI's Discussions on Twitter

Vergleichen Sie PALI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PALI
Palisade Bio Inc
1.85 226.74M 0 -14.07M -12.56M -13.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Palisade Bio Inc Aktie (PALI) Neueste Nachrichten

pulisher
02:51 AM

Price action breakdown for Palisade Bio Inc.Market Rally & Long-Term Growth Stock Strategies - newser.com

02:51 AM
pulisher
02:33 AM

Sector ETF performance correlation with Palisade Bio Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - newser.com

02:33 AM
pulisher
01:39 AM

How moving averages guide Palisade Bio Inc. tradingMarket Trend Report & Growth Oriented Trading Recommendations - newser.com

01:39 AM
pulisher
01:31 AM

Using data filters to optimize entry into Palisade Bio Inc.Quarterly Trade Summary & Growth Focused Entry Point Reports - newser.com

01:31 AM
pulisher
Oct 13, 2025

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 - GlobeNewswire

Oct 13, 2025
pulisher
Oct 13, 2025

Should I hold or sell Palisade Bio Inc. stock in 2025Market Activity Summary & Entry Point Strategy Guides - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What’s next for Palisade Bio Inc. stock pricePortfolio Gains Report & Risk Managed Investment Strategies - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Palisade Bio Inc. showing signs of accumulation2025 Volume Leaders & Growth Focused Entry Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Palisade Bio Receives Canadian Patent for Composition of Product Candidate PALI-2108 - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

Palisade Bio receives Canadian patent for inflammatory bowel drug - Investing.com

Oct 13, 2025
pulisher
Oct 13, 2025

Palisade Bio Announces Grant of Patent for PALI-2108, a First-in-Class PDE4 Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis - Quiver Quantitative

Oct 13, 2025
pulisher
Oct 13, 2025

PALI-2108 patent No. 3,174,137 protects drug through May 28, 2041 — Palisade Bio targets FSCD & UC - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

What MACD and RSI say about Palisade Bio Inc.M&A Rumor & AI Based Trade Execution Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Will Palisade Bio Inc. stock recover after recent dropJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

What analysts say about Palisade Bio Inc stockResistance Breakout Alerts & Rapid Portfolio Strategies - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Palisade Bio Inc. stock trend outlook and recovery pathWeekly Market Report & Weekly High Conviction Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Palisade Bio Inc. stock dividend yield sustainableMarket Rally & Free Community Supported Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Palisade Bio, Inc. Cancels Special Meeting of Stockholders - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

Palisade Bio Announces Cancellation of Special Meeting of Stockholders - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

Special Meeting Cancelled: Palisade Bio Withdraws Proxy Proposals After Failing to Secure Quorum - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Cohen's Point72 Pours $14M in This Biotech Stock That… - inkl

Oct 09, 2025
pulisher
Oct 09, 2025

Statistical indicators supporting Palisade Bio Inc.’s strengthMarket Trend Summary & Stepwise Swing Trade Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How to forecast Palisade Bio Inc. trends using time seriesRate Cut & Reliable Intraday Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why Palisade Bio Inc. (7NS0) stock could outperform next yearJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Ranking Palisade Bio Inc. among high performing stocks via toolsInsider Buying & Breakout Confirmation Trade Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews

Oct 09, 2025
pulisher
Oct 08, 2025

Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut - Sahm

Oct 08, 2025
pulisher
Oct 08, 2025

Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq

Oct 08, 2025
pulisher
Oct 07, 2025

Is It Too Late to Buy Palisade Bio? - StocksToTrade

Oct 07, 2025
pulisher
Oct 07, 2025

Palisade Bio Launches Phantom Unit Plan for Employees - MSN

Oct 07, 2025
pulisher
Oct 06, 2025

Palisade Bio Stock Climbs To 9-Month High After $120M Stock Offering; Retail Sees More Gains Ahead - MSN

Oct 06, 2025
pulisher
Oct 06, 2025

Morning Market Movers: FEMY, PALI, COSM, Seeing Big Swings - RTTNews

Oct 06, 2025
pulisher
Oct 06, 2025

Morning Market Movers: SOPA, CRML, SANM, PALI See Big Swings - RTTNews

Oct 06, 2025
pulisher
Oct 06, 2025

Is Palisade Bio Inc. stock bottoming outMarket Trend Report & Intraday High Probability Setup Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Understanding Palisade Bio Inc.’s price movementJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Palisade Bio Inc. (7NS0) stock sustain breakout momentumJuly 2025 Drop Watch & Fast Moving Trade Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can technical indicators confirm Palisade Bio Inc.’s reversalJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NSC - StocksToTrade

Oct 03, 2025
pulisher
Oct 03, 2025

Palisade Bio: Can It Balance the Volatility? - StocksToTrade

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 04:14:10 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using economic indicators to assess Palisade Bio Inc. potentialWeekly Profit Analysis & Weekly High Return Forecasts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 02:59:00 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Palisade Bio (PALI) Stock Soars 30% on Securing $138M Public Offering Backed by Top Healthcare Players - parameter.io

Oct 03, 2025
pulisher
Oct 03, 2025

Palisade Bio closes $138 million public offering for IBD drug development - Investing.com Nigeria

Oct 03, 2025

Finanzdaten der Palisade Bio Inc-Aktie (PALI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Palisade Bio Inc-Aktie (PALI) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Wei Binxian
Director
Nov 21 '24
Option Exercise
0.00
388
0
855
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):